Earnings summaries and quarterly performance for HORMEL FOODS CORP /DE/.
Research analysts who have asked questions during HORMEL FOODS CORP /DE/ earnings calls.
Heather Jones
Heather Jones Research
8 questions for HRL
Michael Lavery
Piper Sandler & Co.
7 questions for HRL
Pooran Sharma
Stephens Inc.
6 questions for HRL
Rupesh Parikh
Oppenheimer & Co. Inc.
6 questions for HRL
Leah Jordan
Goldman Sachs Group, Inc.
5 questions for HRL
Peter Galbo
Bank of America
5 questions for HRL
Thomas Palmer
Citigroup Inc.
5 questions for HRL
Benjamin Theurer
Barclays Corporate & Investment Bank
4 questions for HRL
Kenneth Goldman
JPMorgan Chase & Co.
3 questions for HRL
Max Gumport
BNP Paribas
3 questions for HRL
Tom Palmer
JPMorgan Chase & Co.
3 questions for HRL
Ben Theurer
Barclays
2 questions for HRL
Chris Downing
BTIG
2 questions for HRL
Erica Eiler
Oppenheimer
2 questions for HRL
Pooran Sanoo
Stephens Inc.
2 questions for HRL
Ryan Hanley
Barclays
2 questions for HRL
Adam Samuelson
The Goldman Sachs Group, Inc.
1 question for HRL
Max Andrew Gumport
BNP Paribas
1 question for HRL
Rahi Parikh
Barclays
1 question for HRL
Thomas Henry
Heather Jones Research
1 question for HRL
Yasmin Deswandhy
Bank of America
1 question for HRL
Yasmine Deswandhy
Bank of America Corporation
1 question for HRL
Recent press releases and 8-K filings for HRL.
- Q1 net sales of $3 billion, up 2% organically, with high single-digit growth in Foodservice and International segments, offset by Retail declines.
- Gross profit was pressured by elevated commodity costs (pork trim +12%, continued beef inflation) and higher logistics; adjusted operating margin was 8.2% and adjusted EPS was $0.34.
- Full-year guidance reaffirmed: organic net sales growth of 1%–4% and adjusted EPS of $1.43–$1.51, with Q2 EPS expected to be flat to slightly up.
- Signed a definitive agreement to sell its whole-bird turkey (hen) business to Life-Science Innovations for minimal fiscal 2026 impact of approximately $50 million in net sales; value-added turkey and the Jennie-O brand remain with Hormel.
- Hormel delivered 2% organic net sales growth and adjusted diluted EPS of $0.34 in Q1 2026, marking its fifth consecutive quarter of organic growth.
- Q1 net sales were $3.0 billion, led by Foodservice’s 10th consecutive quarter of growth and strong International profit, while Retail declined due to strategic exits and cost pressures.
- The company reaffirmed FY 2026 guidance: 1–4% organic net sales growth, 4–10% adjusted operating income growth, and $1.43–1.51 adjusted EPS, with Q2 EPS expected flat to slightly up.
- Hormel agreed to sell its whole bird turkey business to Life-Science Innovations by end of Q2, which will reduce fiscal 2026 net sales by $50 million.
- Hormel Foods delivered its 5th consecutive quarter of 2% organic net sales growth, driven by foodservice (+7%) and international (+8%), despite a 2% retail decline.
- Agreed to sell its whole-bird turkey business for an estimated $50 million net sales impact in fiscal 2026; transaction to close by end of Q2 with minimal effect on adjusted EPS.
- Reaffirmed FY 2026 adjusted guidance: net sales of $12.2–12.5 billion, operating income of $1.02–1.08 billion, and adjusted diluted EPS of $1.43–1.51.
- Hormel Foods reported Q1 net sales just over $3 billion, 2% organic growth, and adjusted EPS of $0.34, marking its fifth consecutive quarter of organic net sales growth.
- Foodservice and International segments saw high single-digit organic net sales growth, while Retail declined, impacted by a strategic exit of select non-core private label snack nut items.
- Gross profit was pressured by elevated commodity input costs (beef, pork trim up 12%) and rising logistics expenses; management expects modest commodity market relief in H2 and reaffirmed FY26 guidance of 1%–4% organic net sales growth and adjusted EPS of $1.43–$1.51.
- The company entered a definitive agreement to sell its whole bird turkey business to Life-Science Innovations (excluding value-added products and Jennie-O brand), expected to close by end of Q2, reducing FY26 net sales by approximately $50 million with minimal earnings impact.
- Net sales of $3.03 billion; organic net sales up 2%; diluted EPS $0.33 and adjusted diluted EPS $0.34.
- Operating income of $244 million (GAAP) and $247 million (adjusted); operating margin 8.0% (GAAP) and 8.2% (adjusted).
- Retail organic net sales down 2%, while Foodservice organic net sales grew 7% and International organic net sales grew 8%.
- Cash flow from operations of $349 million; cash on hand $868 million, inventories $1.6 billion.
- Reaffirmed fiscal 2026 net sales guidance of $12.2–$12.5 billion; updated operating income guidance to $1.02–$1.08 billion; updated diluted EPS guidance to $1.37–$1.46.
- Hormel Foods delivered net sales of $3.03 billion in Q1, with organic net sales up 2% year-over-year.
- Operating income was $244 million (8.0% margin) and adjusted operating income was $247 million (8.2% margin).
- GAAP diluted EPS was $0.33, and adjusted diluted EPS was $0.34; cash flow from operations totaled $349 million.
- Full-year FY2026 guidance updated: net sales of $12.2–12.5 billion, operating income of $1.02–1.08 billion, and diluted EPS of $1.37–1.46; adjusted EPS reaffirmed at $1.43–1.51.
- Hormel delivered its fifth consecutive quarter of ~2% organic net sales growth and beat EPS expectations by $0.02, reaffirming FY2026 guidance of 1–4% organic sales growth and 4–10% adjusted EPS growth.
- The company is divesting its turkey hen business (inclusive of related plant, feed mill and grower contracts) while retaining the Jennie-O tom turkey operations, expecting minimal impact to FY2026 results; the transaction is slated to close at end of Q2.
- To offset 2025 margin pressure from 20–30% raw-material cost increases, Hormel implemented two waves of pricing—completed by early Q2—and launched five strategic initiatives including brand prioritization, SG&A cost cuts and the ongoing Transform & Modernize program.
- Management introduced a refreshed strategic framework centered on eight priority retail brands, growth platforms (e.g., ready-to-eat entrees, substantial snacking, authentic Mexican), supply-chain modernization, technology investments and key leadership hires, targeting 2–3% organic sales growth and 5–7% operating income growth long term.
- At CAGNY 2026, Hormel Foods reaffirmed its fiscal 2026 outlook, targeting organic net sales growth of 1–4% and adjusted diluted EPS growth of 4–10%.
- Preliminary Q1 FY2026 results delivered the 5th consecutive quarter of organic net sales growth, with performance on track to meet expectations.
- The company announced a definitive agreement to sell its whole-bird turkey business, sharpening focus on value-added Jennie-O® turkey; the transaction is expected to close in Q2 FY2026 with minimal impact on adjusted results.
- Four strategic pillars for 2026 were outlined: sharpen focus, implement targeted pricing, transform operations, and reduce costs with reinvestment.
- Hormel reported its fifth consecutive quarter of ~2% organic net sales growth and an EPS beat of $0.02, and reaffirmed FY26 guidance for 1–4% organic net sales growth and 4–10% adjusted EPS growth.
- The company is divesting its whole turkey hen business (including plant, feed mill, and grower contracts) by end of Q2 FY26 with minimal impact on fiscal results, while retaining Jennie-O tom turkey operations.
- For 2026, Hormel is executing strategic initiatives: prioritizing key brands, two waves of pricing to offset cost increases, continuing its Transform and Modernize program, reducing SG&A costs, and enhancing cross-functional collaboration.
- John Ghingo emphasized a protein-centric strategy with the purpose “fueling every day with real food for real life,” focusing on value-added protein portfolio, growth platforms (e.g., Mexican flavors, Flash 180, Oven Ready Bacon), supply chain optimization, tech modernization, and talent acceleration.
- Hormel reported its fifth consecutive quarter of organic net sales growth at ~2% and delivered adjusted EPS $0.02 above expectations in Q1 FY2026 commentary, underscoring momentum.
- The company reaffirmed FY2026 guidance targeting 1–4% organic net sales growth and 4–10% adjusted diluted EPS growth.
- Announced sale of its turkey hen business—including plant, feed mill, live production assets, and grower contracts—with a projected closing at end of Q2 and minimal impact to FY2026 results under a custom manufacturing arrangement.
- Management outlined five key initiatives to bolster margins: brand prioritization, two waves of pricing, Transform & Modernize projects, SG&A cost reductions, and enhanced cross‐functional collaboration.
Quarterly earnings call transcripts for HORMEL FOODS CORP /DE/.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more